Medical Xpress March 23, 2023
By Tokyo Metropolitan Institute of Medical Science

Booster vaccinations against SARS-CoV-2 are being promoted worldwide to counter the coronavirus disease 2019 (COVID-19) pandemic. Recent studies on the effectiveness of the third dose of the vaccine found improved efficacy against SARS-CoV-2 infection and a reduction in hospitalization. However, most studies on the effect of the third vaccination have been limited to a relatively short period of time after the third dose, and few longitudinal analyses of the effects of the third vaccination with an anti−SARS-CoV-2 vaccine have been reported.

Researchers from Tokyo Metropolitan Institute of Medical Science analyzed the longitudinal effect of the third SARS-CoV-2 mRNA vaccination on antibody responses in in Tokyo, Japan. Additionally, antibody responses induced by the fourth vaccination were analyzed.

The levels...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Govt Agencies, Healthcare System, Patient / Consumer, Pharma / Biotech, Provider, Public Health / COVID, Survey / Study, Trends
Pharma Pulse 4/18/24: Is it Fair Certain Biotech Investors Get an Early Look? The Health and Healthcare of Millennials & more
23andMine: CEO Wojcicki aims to take genetics company private
Drugs Like Ozempic And Mounjaro Could Treat Other Conditions—Here’s What Scientists Are Looking At
23andMe CEO Anne Wojcicki considers taking company private
Weight-loss drugs vs. endoscopic sleeve gastroplasty: Which is more effective?

Share This Article